Article

Optimizing commercial distribution as you prepare to launch your CGT

Distribution is a critical key to successful cell and gene therapy (CGT) commercialization. Learn how distribution channel decisions, site of care activation, and a more supportive administrative and financial infrastructure for providers can help you overcome access barriers and successfully launch your therapy.  

Fill out the form below to read the article

Pardot Form

Related resources

Learn more about 3PL partnerships in the pharma and biopharma landscape

White paper

Achieving success in a changing pharmaceutical landscape
Learn more
A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

Factsheet

Cencora integrated submission readiness assessment
Learn more

Article

Cell and gene therapies in the EU – Between scientific excellence and regulatory caution
Learn more

Connect with our cell and gene experts

Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
Abstract